HCP life science innovation ApS: Financial statements 2025
CVR: 40003665
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
HCP life science innovation ApS (CVR 40003665) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -123,907 and a net result of DKK -123,484 compared with DKK -23,109 the year before. Equity in the 2025 report amounted to DKK 115,126. The solvency ratio was 4.9%.
- Gross Profit
- DKK -123,907
- Profit/Loss
- DKK -123,484
- Equity
- DKK 115,126
- Total Assets
- DKK 2,353,983
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -124K | -123K | 115K | 0 |
| 2024 | - | -30K | -23K | 239K | - |
| 2023 | - | -514K | -206K | 262K | - |
| 2022 | - | -471K | -470K | 118K | - |
| 2021 | - | -590K | -509K | 88K | - |
Official annual report
How creditworthy is HCP life science innovation ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout HCP life science innovation ApS
HCP life science innovation ApS is a Danish company of the type Anpartsselskab based in Brande, founded in 2018. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Hans-Christoph Paul. The company is owned by HCP HOLDING ApS. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 9,955 and a net result of DKK 34,931 compared with DKK -123,484 the year before. Equity in the 2026 report amounted to DKK 150,057.
